Image (256d68e4 5603 401b B20a 6bd7a936c6a8 01)
Fenofibrate Tablet
Product Images NDC 69315-288
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 69315-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (256d68e4 5603 401b B20a 6bd7a936c6a8 02)
NDC 69315-287-09 is a package of 90 Fenofibrate tablets, each containing 48 mg of fenofibrate. The medication helps in decreasing cholesterol and triglyceride levels in the blood. The package is child-resistant, and it is recommended to keep it away from moisture. The tablets should be stored at controlled room temperature, and should not be used if the seal is broken. The medication is manufactured by Graviti Pharmaceuticals Pvt. Ltd. in India and distributed by Leading Pharma in the US. The package has a unique identification code- 03011000320.*
Image (256d68e4 5603 401b B20a 6bd7a936c6a8 03)
NDC 69315-288-09 is a bottle of 90 Fenofibrate tablets containing 145 mg of fenofibrate in each tablet. It is manufactured by Graviti Pharmaceuticals in India and distributed by Leading Pharma in the USA. The tablets are stored at room temperature and should be protected from moisture. The package is child-resistant, and the product should not be used if the seal over the bottle opening is missing or broken. For more information on dosage and administration, refer to the package insert.*
Image (256d68e4 5603 401b B20a 6bd7a936c6a8 04)
Fenofibrate Tablets are available in a pack of 500 tablets with each tablet containing 145 mg fenofibrate, USP. It is a prescription medication and the full prescribing information is mentioned in the package insert. The tablets should be stored at 20° to 25°C and protected from moisture. The bottle has a child-resistant cap and should be kept out of the reach of children. The package should not be accepted if the seal over the bottle opening is broken or missing. The manufacturer is Leading Pharma, LLC and it is manufactured by Graviti Pharmaceuticals in India. The latest revision date for this medicine is May 2022. The text includes details about dosage, packaging, storage, and manufacturer information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
